Nitroglycerin
Nitroglycerin, also known as glyceryl trinitrate (GTN), is a nitrate-based vasodilator used to prevent and relieve angina caused by reduced blood flow to the heart. It works by releasing nitric oxide, which relaxes vascular smooth muscle, dilates blood vessels, reduces cardiac workload, and improves the balance between myocardial oxygen supply and demand. Nitroglycerin is available in sublingual tablets and sprays, transdermal patches, topical ointments, and intravenous formulations, depending on the clinical indication. Common side effects include headache, dizziness, flushing, and low blood pressure. It should not be combined with phosphodiesterase-5 inhibitors such as sildenafil or tadalafil because the combination can cause a dangerous drop in blood pressure. Nitroglycerin should be used according to medical instructions, with appropriate monitoring, particularly in patients with hypotension or other cardiovascular conditions.
Nitroglycerin was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Nitroglycerin, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Nitroglycerin from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Nitroglycerin, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
